EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice

Shanshan Jenny Zhong iD, Xiaoling Liu, Tomonori Kaneko, Yan Feng, Owen Hovey iD, Kyle Yang, Sally Ezra, Soon-Duck Ha, Sung Kim iD, John K McCormick, Huadong Liu, Shawn Shun-Cheng Li

Cells · 15.07.2024 · 13 (14) · 1193

DOI: 10.3390/cells13141193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 15.07.2024. Verfasst von Shanshan Jenny Zhong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, B7-H1 Antigen, Peptides, T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The programmed cell death protein 1 (PD-1) plays a critical role in cancer immune evasion. Blocking the PD-1-PD-L1 interaction by monoclonal antibodies has shown remarkable clinical efficacy in treating certain types of cancer. However, antibodies are costly to produce, and antibody-based therapies can cause immune-related adverse events. To address the limitations associated with current PD-1/PD-L1 blockade immunotherapy, we aimed to develop peptide-based inhibitors of the PD-1/PD-L1 interaction as an alternative means to PD-1/PD-L1 blockade antibodies for anti-cancer immunotherapy. Through the functional screening of peptide arrays encompassing the ectodomains of PD-1 and PD-L1, followed by the optimization of the hit peptides for solubility and stability, we have identified a 16-mer peptide, named mL7N, with a remarkable efficacy in blocking the PD-1/PD-L1 interaction both in vitro and in vivo. The mL7N peptide effectively rejuvenated PD-1-suppressed T cells in multiple cellular systems designed to recapitulate the PD-1/PD-L1 interaction in the context of T-cell receptor signaling. Furthermore, PA-mL7N, a chimera of the mL7N peptide coupled to albumin-binding palmitic acid (PA), significantly promoted breast cancer cell killing by peripheral blood mononuclear cells ex vivo and significantly curbed tumor growth in a syngeneic mouse model of breast cancer. Our work raises the prospect that mL7N may serve as a prototype for the development of a new line of peptide-based immunomodulators targeting the PD-1/PD-L1 immune checkpoint with potential applications in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorB7-H1 AntigenPeptidesT-LymphocytesAnimalsMiceHumansFemaleCell Line, TumorProtein BindingCell Proliferation

Stichwörter der Autor:innen

PD-1 ligand-1 (PD-L1)PD-1/PD-L1 blocking peptideimmune checkpoint blockadepeptide-based immunomodulatorprogrammed cell death-1 (PD-1)

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 AntigenPeptides

Autor:innen und Institutionen

  • Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.
  • Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.
  • School of Health and Life Sciences, Health and Rehabilitation University, 369 Dengyun Rd, Qingdao 266071, China.

ORCID-Profile: Shanshan Jenny Zhong, Owen Hovey, Sung Kim

Förderung

  • Canadian Institute of Health Research
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Zhong, S. J., Liu, X., Kaneko, T., Feng, Y., Hovey, O., Yang, K., Ezra, S., Ha, S. D., Kim, S., McCormick, J. K., Liu, H., & Li, S. S. (2024). Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice. Cells, 13(14), 1193. https://doi.org/10.3390/cells13141193

Vancouver

Zhong SJ, Liu X, Kaneko T, Feng Y, Hovey O, Yang K, et al. Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice. Cells. 2024;13(14):1193. doi:10.3390/cells13141193

BibTeX
@article{Zhong2024,
  author = {Zhong, Shanshan Jenny and Liu, Xiaoling and Kaneko, Tomonori and Feng, Yan and Hovey, Owen and Yang, Kyle and Ezra, Sally and Ha, Soon-Duck and Kim, Sung and McCormick, John K and Liu, Huadong and Li, Shawn Shun-Cheng},
  title = {Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {1193},
  doi = {10.3390/cells13141193}
}
Kostenlos starten →